These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28798773)

  • 1. Planktonic Growth of
    Wang JC; Cordero J; Sun Y; Aranke M; Wolcott R; Colmer-Hamood JA; Hamood AN
    Int J Otolaryngol; 2017; 2017():3037191. PubMed ID: 28798773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Fusobacterium nucleatum and coaggregation in anaerobe survival in planktonic and biofilm oral microbial communities during aeration.
    Bradshaw DJ; Marsh PD; Watson GK; Allison C
    Infect Immun; 1998 Oct; 66(10):4729-32. PubMed ID: 9746571
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Li Q; Tan L; Wang H; Kou Y; Shi X; Zhang S; Pan Y
    ACS Infect Dis; 2020 Jul; 6(7):1686-1696. PubMed ID: 32320601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antimicrobial agent, Next-Science, inhibits the development of Staphylococcus aureus and Pseudomonas aeruginosa biofilms on tympanostomy tubes.
    Banerjee D; Tran PL; Colmer-Hamood JA; Wang JC; Myntti M; Cordero J; Hamood AN
    Int J Pediatr Otorhinolaryngol; 2015 Nov; 79(11):1909-14. PubMed ID: 26388185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coaggregation and biofilm growth of Granulicatella spp. with Fusobacterium nucleatum and Aggregatibacter actinomycetemcomitans.
    Karched M; Bhardwaj RG; Asikainen SE
    BMC Microbiol; 2015 May; 15():114. PubMed ID: 26025449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biofilm formation enhances the oxygen tolerance and invasiveness of Fusobacterium nucleatum in an oral mucosa culture model.
    Gursoy UK; Pöllänen M; Könönen E; Uitto VJ
    J Periodontol; 2010 Jul; 81(7):1084-91. PubMed ID: 20350156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective observational case series evaluating middle ear fluid and tympanostomy tubes through pyrosequencing.
    Wang JC; Pillutla P; Cordero J; Hamood AN
    Int J Pediatr Otorhinolaryngol; 2018 Nov; 114():159-165. PubMed ID: 30262357
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Thurnheer T; Karygianni L; Flury M; Belibasakis GN
    Front Microbiol; 2019; 10():1716. PubMed ID: 31417514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoinducer 2 of Fusobacterium nucleatum as a target molecule to inhibit biofilm formation of periodontopathogens.
    Jang YJ; Choi YJ; Lee SH; Jun HK; Choi BK
    Arch Oral Biol; 2013 Jan; 58(1):17-27. PubMed ID: 22633049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy in biofilm formation between Fusobacterium nucleatum and Prevotella species.
    Okuda T; Kokubu E; Kawana T; Saito A; Okuda K; Ishihara K
    Anaerobe; 2012 Feb; 18(1):110-6. PubMed ID: 21945879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased proliferation and decreased membrane permeability as defense mechanisms of Fusobacterium nucleatum against human neutrophilic peptide-1.
    Keskin M; Könönen E; Söderling E; Isik G; Firatli E; Uitto VJ; Gürsoy UK
    Anaerobe; 2014 Dec; 30():35-40. PubMed ID: 25132418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Pathogen
    Li Q; Wang H; Tan L; Zhang S; Lin L; Tang X; Pan Y
    Front Cell Infect Microbiol; 2021; 11():643913. PubMed ID: 33816348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy between Tannerella forsythia and Fusobacterium nucleatum in biofilm formation.
    Sharma A; Inagaki S; Sigurdson W; Kuramitsu HK
    Oral Microbiol Immunol; 2005 Feb; 20(1):39-42. PubMed ID: 15612944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative proteomic analysis of extracellular matrix extracted from mono- and dual-species biofilms of Fusobacterium nucleatum and Porphyromonas gingivalis.
    Mohammed MMA; Pettersen VK; Nerland AH; Wiker HG; Bakken V
    Anaerobe; 2017 Apr; 44():133-142. PubMed ID: 28285095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of extracellular polymeric matrix, and treatment of Fusobacterium nucleatum and Porphyromonas gingivalis biofilms with DNase I and proteinase K.
    Ali Mohammed MM; Nerland AH; Al-Haroni M; Bakken V
    J Oral Microbiol; 2013; 5():. PubMed ID: 23372876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Veillonella Catalase Protects the Growth of Fusobacterium nucleatum in Microaerophilic and Streptococcus gordonii-Resident Environments.
    Zhou P; Li X; Huang IH; Qi F
    Appl Environ Microbiol; 2017 Oct; 83(19):. PubMed ID: 28778894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tympanostomy tube in vitro biofilm potential of common otopathogens.
    Ojano-Dirain C; Antonelli PJ
    Otolaryngol Head Neck Surg; 2012 May; 146(5):816-22. PubMed ID: 22371343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oxygen, inoculum composition and flow rate on development of mixed-culture oral biofilms.
    Bradshaw DJ; Marsh PD; Allison C; Schilling KM
    Microbiology (Reading); 1996 Mar; 142 ( Pt 3)():623-629. PubMed ID: 8868437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural features of tympanostomy tube biofilm formation in ciprofloxacin-resistant Pseudomonas otorrhea.
    Jang CH; Cho YB; Choi CH
    Int J Pediatr Otorhinolaryngol; 2007 Apr; 71(4):591-5. PubMed ID: 17239963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of biofilms on tympanostomy tubes with acetic acid treatment: an in vitro study.
    Kjeldsen M; Homøe P; Kirstine Nielsen A; Crone S; Nørskov Kragh K; Bjarnsholt T
    APMIS; 2020 Jun; 128(6):445-450. PubMed ID: 32277844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.